0001209191-23-018472.txt : 20230314
0001209191-23-018472.hdr.sgml : 20230314
20230314163010
ACCESSION NUMBER: 0001209191-23-018472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230312
FILED AS OF DATE: 20230314
DATE AS OF CHANGE: 20230314
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Konidaris Tasos
CENTRAL INDEX KEY: 0001320982
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38485
FILM NUMBER: 23731456
MAIL ADDRESS:
STREET 1: 103 JFK PARKWAY
CITY: SHORT HILLS
STATE: NJ
ZIP: 07078
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001723128
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
BUSINESS PHONE: (908) 947-3120
MAIL ADDRESS:
STREET 1: 400 CROSSING BOULEVARD
STREET 2: 3RD FLOOR
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Atlas Holdings, Inc.
DATE OF NAME CHANGE: 20171117
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-12
0
0001723128
Amneal Pharmaceuticals, Inc.
AMRX
0001320982
Konidaris Tasos
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER
NJ
08807
0
1
0
0
Executive Vice President & CFO
Class A Common Stock
2023-03-12
4
M
0
87719
A
380840
D
Restricted Stock Units
2023-03-12
4
M
0
87719
0.00
D
Class A Common Stock
87719
87720
D
Represents shares of the Issuer's Class A Common Stock awarded to the reporting person in connection with the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
On March 12, 2020, the reporting person was granted 350,877 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
Denis Butkovic, Attorney-in-Fact
2023-03-14